Key result
BNP testing yielded a diagnostic odds ratio of 27 (85% sensitivity, 84% specificity) for detecting clinical heart failure in symptomatic patients under 80 years old, proving superior to NTproBNP.
Why the study?
Does BNP testing provide better diagnostic accuracy than NTproBNP for clinical heart failure and left ventricular systolic dysfunction?
Meta-Analysis
Does BNP testing provide better diagnostic accuracy than NTproBNP for clinical heart failure and left ventricular systolic dysfunction?
Odds Ratio: 27
BNP is a highly sensitive and specific test for diagnosing clinical heart failure and screening for LV systolic dysfunction, performing better than NTproBNP, though accuracy declines with age.
No takes yet. Share an insight, caveat, or question.
Supports BNP over NTproBNP for HF diagnosis in symptomatic patients <80; confirms superiority via Level 1 meta-analysis.
Ewald et al. (2007) conducted a meta-analysis in Clinical heart failure and left ventricular systolic dysfunction. B type natriuretic peptide (BNP) vs. N-terminal pro B natriuretic peptide (NTproBNP) was evaluated on Diagnosis of clinical heart failure (DOR 27). BNP testing yielded a diagnostic odds ratio of 27 (85% sensitivity, 84% specificity) for detecting clinical heart failure in symptomatic patients under 80 years old, proving superior to NTproBNP.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: